🔎 Trials Near Me

Hjem › Prostatakreft › North Carolina › Durham

Kliniske studier for Prostatakreft i Durham, NC

32 studier for Prostatakreft søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

The Vanguard Study: Testing a New Way to Screen for Cancer

RekruttererFrivillige helsepersonell ønskes velkommen
  • Durham VA Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • Duke University, Durham
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

RekruttererFase 3
  • Durham VA Medical Center, Durham
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

RekruttererFase 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Durham VA Medical Center, Durham
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RekruttererFase 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

DESTINY-PANTUMOUR04

RekruttererObservasjonsstudie
  • Research Site, Durham
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

RekruttererFase 1/2
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT06800313

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

RekruttererFase 3
  • Duke University Medical Center (location of scans), Durham
  • Duke University Medical Center - Duke Cancer Center, Durham
  • Duke University Medical Center - Duke University Hospital (location of scans), Durham
  • og 1 flere
Alder 18 og eldre · Menn · Oppdatert 24. sep. 2026 · NCT07028853

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

RekruttererFase 2
  • Durham VA Medical Center, Durham, NC, Durham
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT04038502

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

RekruttererFase 2
  • Durham VA Medical Center, Durham, NC, Durham
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT05011383

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

RekruttererFase 1
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 15. sep. 2026 · NCT07493512

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

RekruttererFase 3
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RekruttererFase 3
  • Durham VA Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

RekruttererObservasjonsstudie
  • Duke University, Durham
Alder 18 og eldre · Menn · Oppdatert 27. aug. 2026 · NCT07050433

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

RekruttererFase 1
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 21. aug. 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

RekruttererFase 1/2
  • Duke University medical center, Durham
Alder 18 og eldre · Menn · Oppdatert 20. aug. 2026 · NCT06785636

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Duke University, Durham
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

RekruttererFase 2
  • Duke University Medical Center - Duke Cancer Center, Durham
Alder 18 og eldre · Menn · Oppdatert 17. aug. 2026 · NCT06842498

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

RekruttererFase 1
  • Duke Cancer Institute, Durham
Alder 18 og eldre · Menn · Oppdatert 10. aug. 2026 · NCT06067841

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

RekruttererObservasjonsstudie
  • Duke University, Durham
Alder 40 og eldre · Menn · Oppdatert 6. aug. 2026 · NCT07144228

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

RekruttererFase 1
  • Duke Cancer Center, Durham
Alder 18 og eldre · Menn · Oppdatert 9. jul. 2026 · NCT07103018

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

RekruttererFase 1/2
  • Duke University, Durham
Alder 18 og eldre · Menn · Oppdatert 25. jun. 2026 · NCT06457919

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

RekruttererFrivillige helsepersonell ønskes velkommen
  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07463833

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

RekruttererFase 4
  • Duke University Medical Center, Durham
Alder 18 til 100 · Menn · Oppdatert 4. jun. 2026 · NCT05803941

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

RekruttererObservasjonsstudie
  • Durham VA Medical Center, Durham
  • Duke Cancer Network, Durham
  • Duke University, Durham
  • og 1 flere
Alder 21 og eldre · Menn · Oppdatert 22. mai 2026 · NCT03151629

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

RekruttererFase 2/3
  • Durham VA Medical Center, Durham, NC, Durham
Alder 18 og eldre · Menn · Oppdatert 8. apr. 2026 · NCT04787744

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RekruttererFase 1
  • Duke Cancer Institute, Durham
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

RekruttererFase 1
  • Duke Cancer Center, Durham
Alder 18 og eldre · Menn · Oppdatert 4. feb. 2026 · NCT04729114

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Rekrutterer
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. des. 2025 · NCT06965192

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

RekruttererObservasjonsstudie
  • Duke University Medical Center, Durham
Alder 18 og eldre · Menn · Oppdatert 15. okt. 2025 · NCT06141993

Prostatakreft-studier i andre byer

Andre studier i Durham

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.